XORTX Therapeutics Names Michael Bumby as CFO; U.S.-listed Shares Down 4%

MT NewswiresDec 19 08:21 ET

XORTX Therapeutics Inc. Faces Financial Challenges

TipRanksNov 15 11:49 ET

XORTX Initiates Precision Medicine Program

MT NewswiresOct 9 06:32 ET

XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease

MT NewswiresAug 29 08:09 ET

Stocks in Play: XORTX Therapeutics Inc.

Baystreet.caMay 17 11:15 ET

XORTX Therapeutics Reprices Warrants Connected With U.S. IPO

MT NewswiresMay 17 08:16 ET